Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	42.57	46.86	47.01	46.98	47.64
Cash & Short-Term Investments	42.57	46.86	47.01	46.98	47.64
Cash Growth	-9.14%	-0.33%	0.06%	-1.38%	-1.04%
Accounts Receivable	-	-	-	-	0.03
Receivables	-	-	-	-	0.03
Other Current Assets	0.24	0.29	0.33	0.41	0.09
Total Current Assets	42.81	47.15	47.34	47.39	47.75
Long-Term Deferred Tax Assets	-	0.02	0.36	0.2	-
Total Assets	42.81	47.17	47.7	47.59	47.75
Accounts Payable	0.33	0.33	0.33	0.33	0.33
Accrued Expenses	0.04	0.07	0.09	0.09	0.06
Other Current Liabilities	0.36	1.28	1.29	1.28	0.01
Total Current Liabilities	0.73	1.68	1.71	1.7	0.4
Total Liabilities	0.73	1.68	1.71	1.7	0.4
Common Stock	0.74	0.74	0.74	0.74	0.74
Additional Paid-In Capital	70.03	72.16	73.43	74.71	75.98
Retained Earnings	-73.3	-69.89	-70.67	-72.04	-71.86
Total Common Equity	-2.53	3.01	3.51	3.41	4.87
Shareholders' Equity	42.08	45.49	45.99	45.89	47.35
Total Liabilities & Equity	42.81	47.17	47.7	47.59	47.75
Net Cash (Debt)	42.57	46.86	47.01	46.98	47.64
Net Cash Growth	-9.14%	-0.33%	0.06%	-1.38%	-1.04%
Net Cash Per Share	0.57	0.63	0.63	0.63	0.64
Filing Date Shares Outstanding	74.21	74.21	74.21	74.21	74.21
Total Common Shares Outstanding	74.21	74.21	74.21	74.21	74.21
Working Capital	42.08	45.47	45.63	45.69	47.35
Book Value Per Share	-0.03	0.04	0.05	0.05	0.07
Tangible Book Value	-2.53	3.01	3.51	3.41	4.87
Tangible Book Value Per Share	-0.03	0.04	0.05	0.05	0.07

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.